Letter to the Editor
British HIV Association opportunistic infection guidelines: in defence of amphotericin B deoxycholate
Article first published online: 11 OCT 2012
© 2012 British HIV Association
Volume 13, Issue 10, pages 636–637, November 2012
How to Cite
Bicanic, T., Ogden, D., Whitney, L., Loyse, A. and Jarvis, J. (2012), British HIV Association opportunistic infection guidelines: in defence of amphotericin B deoxycholate. HIV Medicine, 13: 636–637. doi: 10.1111/j.1468-1293.2012.01022.x
- Issue published online: 11 OCT 2012
- Article first published online: 11 OCT 2012
- 3WHO Rapid advice: Diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. Available at www.who.int/hiv/pub/cryptococcal_disease2011/en/ (accessed 21 April 2012).
- 5Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-Associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety. Clin Infect Dis 2010; 51: 225–232., , et al.